Curis (CRIS) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Curis (CRIS) is Moderate Underperform.

The composite score behind that read is -0.21, weighing +0.23 of bullish evidence against -0.41 bearish.

Curis last closed at $0.67, -5.63% on the session.

Against the IVW growth benchmark the position is -6.43% over the forecast window.

The read is built from 15 underlying insights — 3 bullish and 12 bearish.

Agreement across those insights is 80%.

20 graded predictions for CRIS so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Curis in the 1st percentile on return on equity, where 100 is best.

Curis is classified under Health Care / Biotechnology, with a market capitalisation of $1.72M.

StockMap tracks Curis as the 380th largest of the 381 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 301 Neutral, 63 Moderate Underperform and 17 Moderate Outperform.

On that composite Curis ranks 323rd of 381 in the group, against a group median of -0.08.